The Business Development & Strategy Team at Fred Hutch has a stellar track record of finding partners who share our drive to innovate, collaborate and accelerate the development of high-impact technologies and therapies. The result has been dozens of licensing agreements, strategic partnerships, spinouts and startups, including such high-profile launches as Juno Therapeutics, Adaptive Biotechnologies, Nohla Therapeutics and Faraday Pharmaceuticals.
We provide state-of-the-art data infrastructure and data science support for our investigators in areas such as data mining, machine learning, mobile app development and bioinformatics.Learn More
We maintain our own 37,000-square-foot facility that produces high-quality stem cell products for research, clinical trials and therapeutic use.
Fred Hutch researchers are eligible to apply for special funding to help them take their discoveries and ideas to a commercially viable stage.